Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

c-Rel in Epidermal Homeostasis: A Spotlight on c-Rel in Cell Cycle Regulation.

Lorenz VN, Schön MP, Seitz CS.

J Invest Dermatol. 2016 Jun;136(6):1090-1096. doi: 10.1016/j.jid.2016.02.003. Epub 2016 Mar 29. Review.

2.

The c-Rel subunit of NF-κB is a crucial regulator of phenotype and motility of HaCaT keratinocytes.

Lorenz VN, Schön MP, Seitz CS.

Arch Dermatol Res. 2015 Aug;307(6):523-30. doi: 10.1007/s00403-015-1562-2. Epub 2015 Apr 5.

PMID:
25842167
3.

Cutting edge: NF-κB p65 and c-Rel control epidermal development and immune homeostasis in the skin.

Grinberg-Bleyer Y, Dainichi T, Oh H, Heise N, Klein U, Schmid RM, Hayden MS, Ghosh S.

J Immunol. 2015 Mar 15;194(6):2472-6. doi: 10.4049/jimmunol.1402608. Epub 2015 Feb 13.

4.

c-Rel downregulation affects cell cycle progression of human keratinocytes.

Lorenz VN, Schön MP, Seitz CS.

J Invest Dermatol. 2014 Feb;134(2):415-422. doi: 10.1038/jid.2013.315. Epub 2013 Jul 26.

5.

Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63.

King KE, Ha L, Camilli T, Weinberg WC.

J Skin Cancer. 2013;2013:632028. doi: 10.1155/2013/632028. Epub 2013 Apr 22.

6.

The c-Rel subunit of NF-κB regulates epidermal homeostasis and promotes skin fibrosis in mice.

Fullard N, Moles A, O'Reilly S, van Laar JM, Faini D, Diboll J, Reynolds NJ, Mann DA, Reichelt J, Oakley F.

Am J Pathol. 2013 Jun;182(6):2109-20. doi: 10.1016/j.ajpath.2013.02.016. Epub 2013 Apr 4.

7.

Differential regulation of nuclear factor-kappa B subunits on epidermal keratinocytes by ultraviolet B and tacrolimus.

Wu CS, Lan CC, Kuo HY, Chai CY, Chen WT, Chen GS.

Kaohsiung J Med Sci. 2012 Nov;28(11):577-85. doi: 10.1016/j.kjms.2012.04.023. Epub 2012 Jul 26.

8.

C/EBPγ regulates wound repair and EGF receptor signaling.

Melchionna R, Bellavia G, Romani M, Straino S, Germani A, Di Carlo A, Capogrossi MC, Napolitano M.

J Invest Dermatol. 2012 Jul;132(7):1908-17. doi: 10.1038/jid.2012.51. Epub 2012 Mar 22.

9.

Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.

Lizzul PF, Aphale A, Malaviya R, Sun Y, Masud S, Dombrovskiy V, Gottlieb AB.

J Invest Dermatol. 2005 Jun;124(6):1275-83.

10.

The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms.

Gugasyan R, Voss A, Varigos G, Thomas T, Grumont RJ, Kaur P, Grigoriadis G, Gerondakis S.

Mol Cell Biol. 2004 Jul;24(13):5733-45.

11.

Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin.

Westergaard M, Henningsen J, Johansen C, Rasmussen S, Svendsen ML, Jensen UB, Schrøder HD, Staels B, Iversen L, Bolund L, Kragballe K, Kristiansen K.

J Invest Dermatol. 2003 Nov;121(5):1104-17.

12.

Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth.

Takao J, Yudate T, Das A, Shikano S, Bonkobara M, Ariizumi K, Cruz PD.

Br J Dermatol. 2003 Apr;148(4):680-8.

PMID:
12752124
13.
14.

Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgård R.

Cancer Res. 1999 Jul 15;59(14):3299-303.

Supplemental Content

Loading ...
Support Center